학술논문
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease
Document Type
Article
Author
Bolla, M.; Neven, A.; Collette, L.; Maingon, P.; Carrie, C.; Boladeras, A.; Andreopoulos, D.; Engelen, A.; Sundar, S.; van der Steen-Banasik, E.M.; Armstrong, J.; Peignaux-Casasnovas, K.; Boustani, J.; Herrera, F.G.; Pieters, B.R.; Slot, A.; Bahl, A.; Scrase, C.D.; Azria, D.; Jansa, J.; O’Sullivan, J.M.; Van Den Bergh, A.C.M.; Van Den Bergh, A.C.M.; Carrie, C.; Villa, S.; Kitsios, N.; Poortmans, Ph.; Bolla, M.; Sundar, S.; Van Der Steen-Banasik, E.M.; Armstrong, J.; Maingon, P.; Bosset, J.-F.; Zouhair, A.; Herrera, F.G.; Pieters, B.R.; Slot, A.; Hopkins, K.; Bahl, A.; Ben Yosef, R.; Budach, V.; Boehmer, D.; Scrase, C.D.; Renard, L.; Magrini, S.M.; De Bari, B.; Jansa, J.; Lartigau, E.; Matuszewska; O’Sullivan, J.M.; Johnston, P.G.; Busetto, M.; Remouchamps, V.; Untereiner, M.; Scandolaro, L.; Dufour, P.; Noël, G.; Syndikus, I.; Haustermans, K.; Marcenaro, M.; Weytjens, R.; Mason, M.; Soete, G.; Krol, A.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 20 September 2021, 39(27):3022-3033)
Subject
Language
English
ISSN
15277755
0732183X
0732183X